Cas no for 5943-30-6,Di-sec-butyl disulfide ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich - PharmaSources.com

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 5943-30-6

5943-30-6

[CAS Name] Di-sec-butyl disulfide

[Formula] C8H18S2

Search Products Post Sourcing Request

Basica Info

[CAS Name]Di-sec-butyl disulfide
[Alias]Di-sec-butyl disulfide; 2-(butan-2-yldisulfanyl)butane; (2R,2'R)-2,2'-disulfanediyldibutane
[Number]5943-30-6
[EINECS]227-702-1
[Formula]C8H18S2
[Molecular weight]178.3585

[Boiling point]220.6°C at 760 mmHg
[Density]0.166mmHg at 25°C
[Flash point]67.2°C

5943-30-6 Suppliers

Company

Main Products

Sanmenxia Aoke Chemical Industry Co., Ltd.

Product Specifications:

Item	Index
Appearance	Colorless transparent liquid
Purity	98.5%min
Water	0.1%max

Send Inquiry

Nanjing King-Pharm Co., Ltd.

sec-butyl disulfide

Send Inquiry

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight January 2025

PharmaSources Customer Service